Why the study?
Despite improvements in STEMI care, total ischemic time remains long in late-presenting patients, prompting evaluation of predictors of presentation at 12 hours or more and long-term mortality.
Does very late presentation (≥12 h) increase long-term mortality in patients with STEMI?
Does very late presentation (≥12 h) increase long-term mortality in patients with STEMI?
Very late presentation (≥12 h) in STEMI is associated with significantly lower long-term survival and is strongly predicted by female sex, diabetes, and absence of chest pain.
Answers are grounded in this paper and cite their sources.
Late STEMI presentation was associated with lower survival; leaves open whether targeted delay-reduction strategies improve outcomes in high-risk groups.
BACKGROUND: Despite improvements in ST elevation myocardial infarction (STEMI) care, total ischemic time remains long in patients who present late. Our goal was to identify predictors of very late presentation (≥12 h) of STEMI and determine long-term mortality. METHODS: We retrospectively examined consecutive patients admitted with STEMI to our institution using the ACTION Registry™. Time of symptom onset to first medical contact (FMC) was calculated and categorized as <12 h or ≥12 h. Predictors of very late presentation were determined. RESULTS: Compared to patients who presented <12 h (n = 365), those who presented ≥12 h (n = 49) after symptom onset were more likely women, diabetics, and those with prior coronary revascularization. In addition, patients who presented ≥12 h had worse ventricular function, were less likely to report chest pain, and were less likely to be transported by ambulance and to undergo coronary angiography. Late presenters had higher rates of heart failure, longer hospitalizations, and were less likely to be discharged home. Diabetes, female sex, and absence of chest pain were strong predictors of late presentation. Long-term survival was significantly lower in late presenters (73% vs. 93%, p = 0.007). CONCLUSIONS: Female sex, diabetes, and absence of chest pain are strong predictors of presentation delay, and long-term mortality is significantly increased in those presenting very late.
No takes yet. Share an insight, caveat, or question.
McNair et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: